Xingen Zhu
Second Affiliated Hospital of Nanchang University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Xingen Zhu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:30 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06284642 · Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)Second Affiliated Hospital of Nanchang University · recruiting · Aneurysmal Subarachnoid Hemorrhage · principal investigator
- N/ANCT05811793 · Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.Second Affiliated Hospital of Nanchang University · unknown · Glioblastoma · principal investigator
- N/ANCT05738083 · Multi-Center Registry Cohort Study on Prognostic Factors and Prediction Model Construction in Aneurysmal SAHSecond Affiliated Hospital of Nanchang University · recruiting · Aneurysmal Subarachnoid Hemorrhage · study chair
- N/ANCT05536024 · Combing a Deep Learning-Based Radiomics With Liquid Biopsy for Preoperative and Non-invasive Diagnosis of GliomaSecond Affiliated Hospital of Nanchang University · completed · Glioma (Diagnosis), Liquid Biopsy, Deep Learning · study director
- N/ANCT05498909 · A Real-world Registry Study of Multidisciplinary Collaborative Diagnosis and Treatment Model for Cardioembolic StrokeXiao Huang · unknown · Cardioembolic Stroke, Multidisciplinary Communication · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:30 UTC. The ranking covers the 200 most relevant of 1073 PubMed records, and a shared surname and initials can bring in a namesake. All 1073 on PubMed
- 763 citationsRCR 33.8
- 358 citationsRCR 18.5
- Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer.J Natl Cancer Inst · 2023253 citationsRCR 23.3
- Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.Lancet Gastroenterol Hepatol · 2021229 citationsRCR 12.7
- Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.JAMA Oncol · 2020202 citationsRCR 9.1
- 198 citationsRCR 12.9
- 193 citationsRCR 16.8
- 188 citationsRCR 23.0
- Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01).J Clin Oncol · 2023173 citationsRCR 10.8
- Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.N Engl J Med · 2021172 citationsRCR 10.3